Back to Search
Start Over
Modulatory effect of filarial infection on the systemic hormone levels in subjects with metabolic syndrome (DM-LF5).
- Source :
- Frontiers in Endocrinology; 11/22/2022, Vol. 13, p1-8, 8p
- Publication Year :
- 2022
-
Abstract
- Aim: Metabolic syndrome (MS) refers to a group of co-morbidities which include central obesity, hypertension, hyperglycemia and dyslipidemia. Previously, we reported that childhood lymphatic filariasis (LF) confers significant protection against type-1 and type-2 forms of diabetes, by means of immunomodulation. In the present study, we studied the effect of LF on endocrine dysfunction in MS and Non-MS patients in baseline and after 10 years of follow-up. Methods: We quantified the serum levels of pancreatic hormones (insulin and glucagon), incretins (Ghrelin, GIP and GLP-1) and adipokines (leptin, adiponectin, adipsin, visfatin, PAI-1 and resistin) by multiplex bead array system. Results: MS (both LF- and LF+) subjects had increased insulin levels compared to NMS (both LF- and LF+) subjects. MS-LF+ subjects had significantly increased levels of glucagon, ghrelin, GIP and GLP-1 and decreased levels of adipsin, compared to MS-LF- subjects. Interestingly this effect was short-lived and was not seen in the follow-up samples. Conclusion: Overall, LF infection might confer limited short-term beneficial effects against MS, by means of modulating the incretin levels,either directly or indirectly. [ABSTRACT FROM AUTHOR]
- Subjects :
- FILARIASIS
METABOLIC syndrome
RESISTIN
GHRELIN
ADIPOKINES
HYPERGLYCEMIA
Subjects
Details
- Language :
- English
- ISSN :
- 16642392
- Volume :
- 13
- Database :
- Complementary Index
- Journal :
- Frontiers in Endocrinology
- Publication Type :
- Academic Journal
- Accession number :
- 160661322
- Full Text :
- https://doi.org/10.3389/fendo.2022.1011942